Risk of diabetes according to the metabolic health status and degree of obesity

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 11, Issue , 2017, Pages S439-S444

  Janghorbani, Mohsen ^a   Salamat, Mohammad Reza ^a   Amini, Masoud ^a   Aminorroaya, Ashraf ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

First degree relatives; Incidence; Metabolic syndrome; Metabolically healthy obese; Obesity; Risk factor; Type 2 diabetes

Indexed keywords

CHOLESTEROL; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; FIRST-DEGREE RELATIVE; FOLLOW UP; HEALTH STATUS; HEMOGLOBIN BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; INCIDENCE; IRAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; METABOLICALLY HEALTHY OBESE; METABOLICALLY UNHEALTHY NORMAL WEIGHT; METABOLICALLY UNHEALTHY OBESE; METABOLICALLY UNHEALTHY OVERWEIGHT; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OBSERVATIONAL STUDY; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; MIDDLE AGED;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; IRAN; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; RISK FACTORS;

EID: 85017252582     PISSN: 18714021     EISSN: 18780334     Source Type: Journal    
DOI: 10.1016/j.dsx.2017.03.032     Document Type: Article

References (29)

1. Whiting, D.R., Guariguata, L., Weil, C., Shaw, J., IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94 (2011), 311–321.
2. Eckel, R.H., Kahn, S.E., Ferrannini, E., Goldfine, A.B., Nathan, D.M., Schwartz, M.W., et al. Obesity and type 2 diabetes: what can be unified and what needs to be individualized. J Clin Endocrinol Metab 96 (2011), 1654–1663.
3. Wildman, R.P., Muntner, P., Reynolds, K., McGinn, A.P., Rajpathak, S., Wylie-Rosett, J., et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999–2004). Arch Intern Med 168 (2008), 1617–1624.
4. Hinnouho, G.M., Czernichow, S., Dugravot, A., Batty, G.D., Kivimaki, M., Singh-Manoux, A., Metabolically healthy obesity and risk of mortality: does the definition of metabolic health matter?. Diabetes Care 36 (2013), 2294–2300.
5. Hinnouho, G.M., Czernichow, S., Dugravot, A., Nabi, H., Brunner, E.J., Kivimaki, M., et al. Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: the Whitehall II cohort study. Eur Heart J 36 (2015), 551–559.
6. Brochu, M., Tchernof, A., Dionne, I.J., Sites, C.K., Eltabbakh, G.H., Sims, E.A., et al. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women. J Clin Endocrinol Metab 86 (2001), 1020–1025.
7. Karelis, A.D., Faraj, M., Bastard, J.P., St-Pierre, D.H., Brochu, M., Prud'homme, D., et al. The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab 90 (2005), 4145–4150.
8. Primeau, V., Coderre, L., Karelis, A.D., Brochu, M., Lavoie, M.E., Messier, V., et al. Characterizing the profile of obese patients who are metabolically healthy. Int J Obes (Lond) 35 (2011), 971–981.
9. Appleton, S.L., Seaborn, C.J., Visvanathan, R., Hill, C.L., Gill, T.K., Taylor, A.W., et al. Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study. Diabetes Care 36 (2013), 2388–2394.
10. Meigs, J.B., Wilson, P.W., Fox, C.S., Vasan, R.S., Nathan, D.M., Sullivan, L.M., et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 91 (2006), 2906–2912.
11. Calori, G., Lattuada, G., Piemonti, L., Garancini, M.P., Ragogna, F., Villa, M., et al. Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study. Diabetes Care 34 (2011), 210–215.
12. Kramer, C.K., Zinman, B., Retnakaran, R., Are metabolically healthy overweight and obesity benign conditions? A systematic review and meta-analysis. Ann Intern Med 159 (2013), 758–769.
13. Bluher, M., Are there still healthy obese patients?. Curr Opin Endocrinol Diabetes Obes 19 (2012), 341–346.
14. Arnlöv, J., Sundström, J., Ingelsson, E., Lind, L., Impact of BMI and the metabolic syndrome on the risk of diabetes in middle-aged men. Diabetes Care 34 (2011), 61–65.
15. Arnlöv, J., Ingelsson, E., Sundström, J., Lind, L., Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation 121 (2010), 230–236.
16. Twig, G., Afek, A., Derazne, E., Tzur, D., Cukierman-Yaffe, T., Gerstein, H.C., et al. Diabetes risk among overweight and obese metabolically healthy young adults. Diabetes Care 37 (2014), 2989–2995.
17. Aung, K., Lorenzo, C., Hinojosa, M.A., Haffner, S.M., Risk of developing diabetes and cardiovascular disease in metabolically unhealthy normal weight and metabolically healthy obese individuals. J Clin Endocrinol Metab 99 (2014), 462–468.
18. Jung, H.C., Lee, J.M., Kang, M.Y., Jang, E.J., Leem, J., Hwang, Y.J., et al. The risk of incident type 2 diabetes in a Korean metabolically healthy obese population: the role of systemic inflammation. J Clin Endocrinol Metab, 2014, 20143885.
19. Blüher, M., Are metabolically healthy obese individuals really healthy. Eur J Endocrinol 171 (2014), R209–19.
20. Amini, M., Janghorbani, M., Diabetes and impaired glucose regulation in first degree relatives of patients with type 2 diabetes in Isfahan, Iran: prevalence and risk factors. Rev Diabetes Stud, 476, 2007, 169.
21. Standard of medical care in diabetes-2017: summary of revisions. Diabetes Care 40:Suppl. 1 (2017), S4–S5.
22. Friedewald, W.T., Levy, R.I., Fredrickson, D.S., Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972), 499–502.
23. Alberti, K.G., Eckel, R.H., Grundy, S.M., Zimmet, P.Z., Cleeman, J.I., Donato, K.A., et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120 (2009), 1640–1645.
24. Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults, Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection evaluation and treatment of high blood cholesterol in adults (Adult treatment panel III). J Am Med Assoc 285 (2001), 2486–2497.
25. Bell, J.A., Kivimaki, M., Hamer, M., Metabolically healthy obesity and risk of incident type 2 diabetes: a meta-analysis of prospective cohort studies. Obes Rev 15 (2014), 504–515.
26. Ryoo, J.H., Park, S.K., Ye, S., Choi, J.M., Oh, C.M., Kim, S.Y., et al. Estimation of risk for diabetes according to the metabolically healthy status stratified by degree of obesity in Korean men. Endocrine 50 (2015), 650–658.
27. Lorenzo, C., Okoloise, M., Williams, K., Stern, M.P., Haffner, S.M., San Antonio Heart Study, The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care 26 (2003), 3153–3159.
28. Kim, N.H., Seo, J.A., Cho, H., Seo, J.H., Yu JH, Yoo HJ, Kim, S.G., et al. Risk of the development of diabetes and cardiovascular disease in metabolically healthy obese people: the Korean genome and epidemiology study. Medicine (Baltimore), 95, 2016, e3384.
29. Lee, S.H., Yang, H.K., Ha, H.S., Lee, J.H., Kwon, H.S., Park, Y.M., et al. Changes in metabolic health status over time and risk of developing type 2 diabetes: a prospective cohort study. Medicine (Baltimore), 94, 2015, e1705.